yana-notes

@Co-agonists differentially tune GluN2B-NMDA receptor trafficking at hippocampal synapses (Ferreira et al. 2017)

2022-04-29: reference:

@Co-agonists differentially tune GluN2B-NMDA receptor trafficking at hippocampal synapses (Ferreira et al. 2017) #


  • There is little evidence that NMDAR subtypes have a preferred co-agonist.

  • D-serine alters the membrane dynamics and content of GluN2B-NMDAR, but not GluN2A-NMDAR, at synapses through a process requiring PDZ binding scaffold partners.

    • It’s only natural to assume that PDZs mediate internalization, plasticity, etc. But are they just work horses and levers, or is it worth checking out?
      • In particular, changes in the postsynaptic scaffold apparatus have been thoroughly investigated during development, providing evidence that PDZ-scaffold proteins (e.g. SAP-102, PSD-95) are differentially involved in the regulation of the GluN2A/B subunit ratio: SAP102 mediates synaptic clearance of NMDA receptors,
      • extracellular molecules (e.g. reelin, ephrinB) and genetic mechanisms (e.g. transcriptional repressor REST) have also been identified as important regulators of the GluN2-NMDAR switch
  • D-Serine causes internalization of NR2B through modulation of the receptor’s C-terminus interactions. Thus, genetic removal of D-serine prevents the synaptic shift:

    • Single-neuron genetic deletion of Serine Racemase resulted in the elimination of LTP at 1 month of age, which could be rescued by exogenous d-serine. Interestingly, there was a restoration of LTP by 2 months of age that was associated with an upregulation of synaptic NR2B
  • The decreased interaction between GluN2B-NMDAR and PSD-95 after D-serine incubation may favor the receptor endocytosis by unmasking a GluN2B internalization signal